APA (7th ed.) Citation

Takeshima, T., Sakai, F., Hirata, K., Imai, N., Matsumori, Y., Yoshida, R., . . . Mikol, D. D. (2021). Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study. Headache: The Journal of Head & Face Pain, 61(6), 927. https://doi.org/10.1111/head.14138

Chicago Style (17th ed.) Citation

Takeshima, Takao, Fumihiko Sakai, Koichi Hirata, Noboru Imai, Yasuhiko Matsumori, Ryuji Yoshida, Cheng Peng, Sunfa Cheng, and Daniel D. Mikol. "Erenumab Treatment for Migraine Prevention in Japanese Patients: Efficacy and Safety Results from a Phase 3, Randomized, Double‐blind, Placebo‐controlled Study." Headache: The Journal of Head & Face Pain 61, no. 6 (2021): 927. https://doi.org/10.1111/head.14138.

MLA (9th ed.) Citation

Takeshima, Takao, et al. "Erenumab Treatment for Migraine Prevention in Japanese Patients: Efficacy and Safety Results from a Phase 3, Randomized, Double‐blind, Placebo‐controlled Study." Headache: The Journal of Head & Face Pain, vol. 61, no. 6, 2021, p. 927, https://doi.org/10.1111/head.14138.